Literature DB >> 20219408

Iron and reactive oxygen species activity in parkinsonian substantia nigra.

Anna Wypijewska1, Jolanta Galazka-Friedman, Erika R Bauminger, Zbigniew K Wszolek, Katherine J Schweitzer, Dennis W Dickson, Andrzej Jaklewicz, Danek Elbaum, Andrzej Friedman.   

Abstract

OBJECTIVES: We sought to determine concentrations of total and labile iron in substantia nigra from patients with Parkinson disease and from controls to assess if oxidative stress is triggered by an increased concentration of iron.
METHODS: Total iron concentration in the whole substantia nigra was evaluated in 17 parkinsonian and 29 control samples. Concentrations of labile iron and copper were assessed in 6 parkinsonian and 8 control samples. The total iron concentration, the Fe(2+)/Fe(3+) ratio, and iron-binding compounds were determined by Mössbauer spectroscopy. Labile iron and copper were measured by electrothermal atomic absorption spectrometry. Activity of reactive oxygen species was evaluated by visible light fluorescence.
RESULTS: The labile iron concentration was significantly higher and corresponded to significantly higher reactive oxygen species activity in parkinsonian vs control samples. No significant difference was found in the total concentrations of copper or iron in the whole substantia nigra between parkinsonian and control samples. Mössbauer spectroscopy detected no Fe(2+) in any samples.
CONCLUSIONS: The substantia nigra of parkinsonian patients contained more labile iron compared with that of controls. This labile iron generated higher reactive oxygen species activity. The oxidative stress damage in parkinsonian substantia nigra may be related to an excess of labile iron and not of the total iron in the diseased tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219408     DOI: 10.1016/j.parkreldis.2010.02.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  46 in total

1.  The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.

Authors:  Alin Ciobica; Zenovia Olteanu; Manuela Padurariu; Lucian Hritcu
Journal:  J Physiol Biochem       Date:  2011-10-18       Impact factor: 4.158

2.  Substantia nigra echogenicity in Parkinson's disease: relation to serum iron and C-reactive protein.

Authors:  Uwe Walter; Rike Witt; Alexander Wolters; Matthias Wittstock; Reiner Benecke
Journal:  J Neural Transm (Vienna)       Date:  2011-05-31       Impact factor: 3.575

3.  In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.

Authors:  Daniel E Huddleston; Jason Langley; Jan Sedlacik; Kai Boelmans; Stewart A Factor; Xiaoping P Hu
Journal:  Hum Brain Mapp       Date:  2017-02-27       Impact factor: 5.038

Review 4.  Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients.

Authors:  Dominic J Hare; Manfred Gerlach; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-09-13       Impact factor: 3.575

5.  Changing iron content of the mouse brain during development.

Authors:  Gregory P Holmes-Hampton; Mrinmoy Chakrabarti; Allison L Cockrell; Sean P McCormick; Louise C Abbott; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2012-07-19       Impact factor: 4.526

6.  Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Christopher Gatenby; Sally Friend; Kenneth R Maravilla; Shu-Ching Hu; Kevin C Cain; Pinky Agarwal; Yoshimi Anzai
Journal:  J Neurol Sci       Date:  2017-04-23       Impact factor: 3.181

7.  Low-molecular-mass metal complexes in the mouse brain.

Authors:  Sean P McCormick; Mrinmoy Chakrabarti; Allison L Cockrell; Jinkyu Park; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2013-03       Impact factor: 4.526

Review 8.  Iron accumulation in Parkinson's disease.

Authors:  Hideki Mochizuki; Toru Yasuda
Journal:  J Neural Transm (Vienna)       Date:  2012-10-16       Impact factor: 3.575

9.  Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.

Authors:  Parastou Foroutan; Melissa E Murray; Shinsuke Fujioka; Katherine J Schweitzer; Dennis W Dickson; Zbigniew K Wszolek; Samuel C Grant
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

10.  Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Cyrus P Zabetian; Shu-Ching Hu; Pinky Agarwal; Dora Yearout; Harvey Checkoway
Journal:  J Neural Transm (Vienna)       Date:  2016-06-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.